First Trust Nasdaq Pharmaceuticals ETFFTXH
- AUM
- $1.2B
- Fee
- 0.60%
- Yield
- 0.7%
- Bumpy · 1Y
- 1.3×S&P
- Volume
- 112K
- NAV
- $43.42
52-week range4% below the high
$29.89$45.10
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +0.7% | +7.4% | +8.3% | +32.4% | +45.1% | +87.2% | +77.2% | +140.5% |
| Peer average | +0.8% | +5.8% | +2.9% | +20.5% | +29.5% | +75.3% | +27.5% | — |
| S&P 500 · VOO | +0.3% | −5.0% | −4.6% | +8.7% | +9.8% | +80.8% | +71.8% | — |
FTXH in One Breath
FTXH Among Health Care ETFs
YTDEnd-of-day Nov 8, 2026 · 33 Health care ETFs by YTD
$10,000 in FTXH
5Y$10,000 in FTXH became
$17,719
In the S&P 500 (VOO)
$17,177
Total return, dividends in · Oct 29, 2021 – Nov 6, 2026 · S&P 500 uses VOO
FTXH’s Top Holdings
TodayLLYEli Lilly and Company8.1%ABBV7.7%PFE7.2%JNJ7.0%MRK6.8%VTRS3.9%GILD3.9%REGN3.9%BIIB3.9%AMGN3.7%ZTS3.7%VRTX3.4%UTHR3.4%INCY3.3%BMY3.2%EXEL2.6%JAZZ2.5%HALO1.7%ILMN1.7%MEDP1.5%NBIX1.3%ELAN28 more
LLYEli Lilly and Company8.1%ABBV7.7%PFE7.2%JNJ7.0%MRK6.8%VTRS3.9%GILD3.9%REGN3.9%BIIB3.9%AMGN3.7%ZTSVRTX38 more
Drug Manufacturers - GeneralBiotechnologyDrug Manufacturers - SpecialtyMedical - Diagnostics
First Trust FTXH · 50 holdings · tile size = share of the fund · as of Nov 6, 2026
What FTXH Holds
TodayDrug Manufacturers - General51.7%
LLY 8.1 · ABBV 7.7 · PFE 7.2 · JNJ 7.0 · MRK 6.8 · GILD 3.9 · BIIB 3.9
Biotechnology33.2%
REGN 3.9 · VRTX 3.4 · UTHR 3.4 · INCY 3.3 · EXEL 2.6 · JAZZ 2.5 · HALO 1.7
Drug Manufacturers - Specialty & Generic9.8%
VTRS 3.9 · ZTS 3.7 · ELAN 1.2 · AMRX · ALKS
Medical - Diagnostics & Research4.7%
ILMN 1.7 · MEDP 1.5 · CRL 1.0 · GH
Medical - Pharmaceuticals0.6%
LQDA · CORT
First Trust FTXH · share of the fund by industry · as of Nov 6, 2026
Eli’s Share of FTXH
Today8.1%
$81 of every $1,000 in FTXH is Eli
Eli held by FTXH
$95.8M
First Trust FTXH · each square = $10 of $1,000 · as of Nov 6, 2026
FTXH’s Share of Health Care ETFs
Today1.1%
of the $110B in 39 Health care ETFs
$1.2B1.1%
$49.9B45.4%
$19.1B17.3%
$39.9B36.2%
Health care ETF AUM · Nov 8, 2026
FTXH Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 8, 2026
Inside FTXH
50 holdings · as of Nov 6, 2026FTXH
First Trust Nasdaq Pharmaceuticals ETF
Today| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 8.11% |
| 2 | ABBV | AbbVie | 7.73% |
| 3 | PFE | Pfizer | 7.22% |
| 4 | JNJ | Johnson & Johnson | 7.04% |
| 5 | MRK | Merck & | 6.84% |
| 6 | VTRS | Viatris | 3.95% |
| 7 | GILD | Gilead Sciences | 3.94% |
| 8 | REGN | Regeneron Pharmaceuticals | 3.88% |
| 9 | BIIB | Biogen | 3.87% |
| 10 | AMGN | Amgen | 3.68% |
Drug Manufacturers - GeneralBiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsMedical - Pharmaceuticals
First Trust FTXH · current holdings by weight · as of Nov 6, 2026 · each tile is one holding · top 20 = 83.2%
All FTXH Holdings
51 holdings · as of Nov 6, 2026FTXH
FTXH’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | Healthcare | 8.11% | $810.99 | 70K | $95.1M |
| 2 | ABBVAbbVie | Healthcare | 7.73% | $772.73 | 314K | $90.6M |
| 3 | PFEPfizer | Healthcare | 7.22% | $721.73 | 2.8M | $84.7M |
| 4 | JNJJohnson & Johnson | Healthcare | 7.04% | $704.19 | 303K | $82.6M |
| 5 | MRKMerck | Healthcare | 6.84% | $683.61 | 546K | $80.2M |
| 6 | VTRSViatris | Healthcare | 3.95% | $394.93 | 2.4M | $46.3M |
| 7 | GILDGilead Sciences | Healthcare | 3.94% | $393.56 | 275K | $46.2M |
| 8 | REGNRegeneron Pharmaceuticals | Healthcare | 3.88% | $388.43 | 50K | $45.6M |
| 9 | BIIBBiogen | Healthcare | 3.87% | $386.99 | 186K | $45.4M |
| 10 | AMGNAmgen | Healthcare | 3.68% | $367.97 | 94K | $43.2M |
| 11 | ZTSZoetis | Healthcare | 3.66% | $366.04 | 523K | $42.9M |
| 12 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 3.42% | $342.42 | 74K | $40.2M |
| 13 | UTHRUnited Therapeutics | Healthcare | 3.38% | $338.22 | 70K | $39.7M |
| 14 | INCYIncyte | Healthcare | 3.26% | $325.52 | 324K | $38.2M |
| 15 | BMYBristol-Myers Squibb Company | Healthcare | 3.25% | $324.78 | 603K | $38.1M |
First Trust FTXH · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 6, 2026
How It Compares
FTXH
First Trust Nasdaq Pharmaceuticals ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 9, 2026 · sorted by AUM
Head to Head
Put FTXH head to head with XLV →XLV vs FTXH
YTDYear to date
FTXH wins+11.6 pts
Past year
FTXH wins+16.1 pts
Fee
XLV winslower fee
Yield
XLV wins+0.7 pts
AUM
XLV42.3× more
2–2level
SPDR XLV and First Trust FTXH · year-to-date · as of Nov 9, 2026 · AUM not scored
FTXH vs VOO
YTDFTXH · First Trust Nasdaq Pharmaceuticals
+32.4%
VOO · S&P 500
+8.7%
Gap
23.7 pts
First Trust FTXH and Vanguard VOO · YTD total return · as of Nov 9, 2026
FTXH vs Its Peer Average
YTDFTXHAvsBPeer average
1D+0.7%+0.8%
1M+7.4%+5.8%
3M+8.3%+2.9%
YTD+32.4%+20.5%
1Y+45.1%+29.5%
3Y+87.2%+75.3%
5Y+77.2%+27.5%
6–1FTXH wins
38 Health care peers · each row scaled to its leader
How Bumpy Is FTXH?
ViewFTXH
How Bumpy
1Y1.3×the S&P 500’s swings
CalmerBumpierS&P 1×FTXH
Calm rank among 7 health care funds#5
Other health care funds1.2× to 2.2×
First Trust FTXH · daily swings over the past year vs the S&P 500
FTXH
Worst Drop
1Y−7.5%from its Feb 27 high
Still below the high−3.2%
$10,000 at the high is now$9,680
First Trust FTXH · fall from the highest close, past year
FTXH
On a Bad Day
1Y0.2×the S&P 500’s fall
FTXH’s worst day: Thursday, Nov 5Up days50 of every 100
S&P 500 up days52 of every 100
First Trust FTXH · average move on days the S&P 500 fell
FTXH
Return for the Bumps
1Y#1 of 7 health care fundsRanked by return above cash for each unit of bumpiness (Sharpe ratio) · cash = 3.8%
FTXH
Cost
Today$60a year per $10,000
Expense ratio 0.60%, taken from the fund’s value
FTXH
Volatility & Beta
1Y18.3%annual volatility
S&P 500 volatility13.6%
Downside volatility10.9%
Beta vs SPY0.46
Correlation vs SPY0.35
Beta rank, lowest first, of 7#6
Daily total returns × √252 · past 254 trading days
FTXH
Max Drawdown
1Y−7.5%peak to trough
Peak closeFeb 27, 2026
Current drawdown−3.2%
Worst day−3.86% · Nov 5
Closing prices, dividends in
FTXH
Up / Down Capture
1Y22%down capture vs SPY
Up ÷ down capture3.00
Up days50.0% (S&P 52.0%)
Average daily move on SPY up days and down days
FTXH
Sharpe & Sortino vs Peers
1YSharpe = (return − 3.8% cash) ÷ volatility · Sortino uses downside volatility only
FTXH
Trading
Today+0.02%above its holdings’ value
Close$43.43
NAV$43.42
Fee per $10,000$60 a year
Avg. volume 30D114K shares
Close vs net asset value, Nov 6
The Details
FTXH
Fund Facts
Today2016launched Sep 20
Tracks[…]
Exchange · CUSIPNASDAQ · 33738R837
StructureETF
Leverage1x
Cost on $10,000$60 a year
Go deeper
First Trust FTXH · fund facts · as of Nov 9, 2026
FTXH
Payouts by Year
11Y$0.0113per share, Sep 2026
Distribution yield0.7%
PaidEvery quarter
Latest ex-date · paidSep 24 · Sep 30, 2026
12 payouts added up$1.20 a share
First Trust FTXH · distributions by ex-date · 2016–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗SEC reported portfolio · 2025-09-30 ↗SEC reported portfolio · 2025-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗SEC reported portfolio · 2024-09-30 ↗SEC reported portfolio · 2024-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-03-31 ↗SEC reported portfolio · 2023-12-31 ↗SEC reported portfolio · 2023-09-29 ↗SEC reported portfolio · 2023-06-30 ↗SEC reported portfolio · 2023-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-03-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-12-30 ↗
Trading & Liquidity
Net asset value$43.42
Premium / discount[…]
Median spread · 30D[…]
Volume today112K
Average volume · 30D114K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.60%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$60.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.0113 |
| Jun 25, 2026 | Jun 30, 2026 | $0.0920 |
| Mar 26, 2026 | Mar 31, 2026 | $0.0573 |
| Dec 12, 2025 | Dec 31, 2025 | $0.13 |
| Sep 25, 2025 | Sep 30, 2025 | $0.15 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0892 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0992 |
| Dec 13, 2024 | Dec 31, 2024 | $0.13 |
| Sep 26, 2024 | Sep 30, 2024 | $0.12 |
| Jun 27, 2024 | Jun 28, 2024 | $0.13 |
| Mar 21, 2024 | Mar 28, 2024 | $0.0676 |
| Dec 22, 2023 | Dec 29, 2023 | $0.12 |
Issuer contentFrom First TrustHear the strategy from the people behind FTXH.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →